Brazil Drug Testing Market Size & Outlook, 2024-2030
Related Markets
Brazil drug testing market highlights
- The Brazil drug testing market generated a revenue of USD 436.0 million in 2024 and is expected to reach USD 555.2 million by 2030.
- The Brazil market is expected to grow at a CAGR of 4.3% from 2025 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Rapid Testing Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Drug testing market data book summary
| Market revenue in 2024 | USD 436.0 million |
| Market revenue in 2030 | USD 555.2 million |
| Growth rate | 4.3% (CAGR from 2025 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Rapid Testing Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
Other key industry trends
- In terms of revenue, Brazil accounted for 3.1% of the global drug testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil drug testing market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 555.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Testing Market Scope
Drug Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Omega Laboratories | View profile | 101-250 | Mogadore, Ohio, United States, North America | https://www.omegalaboratories.com/ |
| Legacy Medical | View profile | 11-50 | Bismarck, North Dakota, United States, North America | https://legacymedical.com |
| Cordant Health Solutions | View profile | 501-1000 | Flagstaff, Arizona, United States, North America | https://cordantsolutions.com |
| Clinical Reference Laboratory | View profile | 501-1000 | Lenexa, Kansas, United States, North America | https://www.crlcorp.com |
| Draegerwerk AG & Co KGaA | View profile | 16476 | Moislinger Allee 53–55, Lubeck, Germany, 23542 | https://www.draeger.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Brazil drug testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 35.89% in 2024. Horizon Databook has segmented the Brazil drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of drug abuse in Brazil is anticipated to be a major factor boosting the demand for testing in the region. To fulfill the growing demand for drug testing, several key players operating in the market are entering the Brazil drug testing market by implementing organic and inorganic growth strategies.
In September 2019, Psychemedics Corporation entered into a new distribution agreement with Toxicologia Pardini Ltda. and Sansão Holding S.A. in Brazil. As per the new contract, Toxicologia Pardini and Sansao were designated as distributors of Psychemedics’ hair drug testing services in Brazil.
Furthermore, in October 2019, Omega Laboratories obtained DENATRAN accreditation for its São Paulo facility, Omega Global Laboratory Services Do Brazil. With this initiative, the company expanded its operations in Brazil. In addition, preventive policies introduced by the government are expected to have a positive impact on the market growth.
Reasons to subscribe to Brazil drug testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil drug testing market databook
-
Our clientele includes a mix of drug testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil drug testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil Drug Type - Drug Testing Market size, 2024 - 2030 (US$M)
Brazil Drug Testing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
